Systemic Effects by Intrathecal Administration of Triamcinolone Acetonide in Patients With Multiple Sclerosis

In patients suffering from multiple sclerosis (MS), intrathecal injection of triamcinolone acetonide (TCA) has been shown to improve symptoms of spasticity. Although repeated intrathecal injection of TCA has been used in a number of studies in late-stage MS patients with spinal cord involvement, no...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Front Endocrinol (Lausanne)
Autors principals: Hoeflich, Andreas, Fitzner, Brit, Walz, Christina, Hecker, Michael, Tuchscherer, Armin, Bastian, Manuela, Brenmoehl, Julia, Schröder, Ina, Willenberg, Holger S., Reincke, Martin, Zettl, Uwe Klaus
Format: Artigo
Idioma:Inglês
Publicat: Frontiers Media S.A. 2020
Matèries:
Endocrinology
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7481359/
https://ncbi.nlm.nih.gov/pubmed/32982971
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fendo.2020.00574
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars